Gepant Adverse Events Chart
Cerebral TorqueShare
| Adverse Event Category | Rimegepant (Nurtec ODT) | Atogepant (Qulipta) | Ubrogepant (Ubrelvy) |
|---|---|---|---|
| Gastrointestinal (Stomach and digestive system) | - Highest severity of nausea - Moderate incidence of constipation - Reports of abdominal pain |
- Most frequent overall gastrointestinal issues - Highest prominence of constipation - Reports of decreased appetite |
- Less prominent than others - Some reports of nausea and vomiting - Occasional abdominal discomfort |
| Skin and Subcutaneous Tissue | - Most frequent rash and pruritus (itching) - Highest severity of alopecia (hair loss) - Reports of urticaria (hives) |
- Secondary severity of alopecia - Some reports of rash and pruritus - Occasional skin hypersensitivity (increased skin sensitivity) |
- Less prominent than others - Few reports of rash and pruritus - Rare cases of angioedema |
| Cardiac | - Strongest overall cardiac adverse events signal - Reports of palpitations - Some cases of chest discomfort |
- Strong signals for cardiac flutter (irregular heartbeat) - Reports of tachycardia (rapid heart rate) - Some cases of hypertension |
- Comparable rates to others - Occasional reports of chest pain - Few cases of bradycardia (slow heart rate) |
| Musculoskeletal and Connective Tissue | - Less prominent than others - Some reports of myalgia (muscle pain) - Occasional arthralgia (joint pain) |
- Moderate reports of back pain - Some cases of muscle spasms - Occasional reports of joint stiffness |
- Most positive signals for skeletal muscle adverse events - Increased signals for muscle tightness and neck pain - Reports of muscle weakness |
| Raynaud's Phenomenon (Poor blood flow to fingers and toes) | - Strongest signal - More frequent reports of cold extremities - Cases of color changes in fingers/toes |
- Secondary signal strength - Some reports of tingling in extremities - Occasional numbness in fingers/toes |
- Least prominent - Rare reports of Raynaud's-like symptoms - Few cases of sensitivity to cold |
| Hepatobiliary (Liver-related) | - Scarce reports across all three gepants - Severe AEs detected in clinical trials, not in post-marketing data - Occasional reports of elevated liver enzymes (indicators of liver stress) - Rare cases of jaundice (yellowing of skin/eyes) reported - Continued monitoring recommended for all gepants |
||
Data source: VigiAccess and FDA Adverse Event Reporting System (FAERS) databases up to March 31, 2024.
Note: This chart summarizes key findings and does not represent a comprehensive list of all adverse events. The frequency and severity of adverse events may vary among individuals.
